650 related articles for article (PubMed ID: 20168275)
21. Band-shaped keratopathy in Chinese patients with Vogt-Koyanagi-Harada syndrome.
Yang P; Sun M
Cornea; 2011 Dec; 30(12):1336-40. PubMed ID: 21934492
[TBL] [Abstract][Full Text] [Related]
22. Inflammatory vitiligo in Vogt-Koyanagi-Harada disease.
Tsuruta D; Hamada T; Teramae H; Mito H; Ishii M
J Am Acad Dermatol; 2001 Jan; 44(1):129-31. PubMed ID: 11148490
[TBL] [Abstract][Full Text] [Related]
23. Uveitis survey in children.
Hamade IH; Al Shamsi HN; Al Dhibi H; Chacra CB; Abu El-Asrar AM; Tabbara KF
Br J Ophthalmol; 2009 May; 93(5):569-72. PubMed ID: 19074918
[TBL] [Abstract][Full Text] [Related]
24. [Therapeutic regimen in Vogt-Koyanagi-Harada syndrome].
Yang P; Wang H; Zhou H; Zhong H; Li F; Huang X; Zhong H; Fu T
Zhonghua Yan Ke Za Zhi; 2002 Apr; 38(4):196-9. PubMed ID: 12133384
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore.
Chee SP; Jap A; Bacsal K
Am J Ophthalmol; 2009 Jan; 147(1):154-161.e1. PubMed ID: 18834575
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
Andrade RE; Muccioli C; Farah ME; Nussenblatt RB; Belfort R
Am J Ophthalmol; 2004 Mar; 137(3):572-4. PubMed ID: 15013890
[TBL] [Abstract][Full Text] [Related]
27. Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease.
Urzua CA; Velasquez V; Sabat P; Berger O; Ramirez S; Goecke A; Vásquez DH; Gatica H; Guerrero J
Acta Ophthalmol; 2015 Sep; 93(6):e475-80. PubMed ID: 25565265
[TBL] [Abstract][Full Text] [Related]
28. Vogt-Koyanagi-Harada disease.
O'Keefe GA; Rao NA
Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
[TBL] [Abstract][Full Text] [Related]
29. [Recurrent uveitis with bilateral exudative retinal detachment. 10-year-old boy with bilaterally impaired vision and eye pain. Vogt-Koyanagi-Harada syndrome].
Kohnen EM; Pansdorf Y; Zubcov A
Ophthalmologe; 2004 Apr; 101(4):390-3. PubMed ID: 15067421
[No Abstract] [Full Text] [Related]
30. The outcomes of indocyanine green angiography monitored immunotherapy in Vogt-Koyanagi-Harada disease.
Chee SP; Jap A
Br J Ophthalmol; 2013 Feb; 97(2):130-3. PubMed ID: 23212203
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the clinical efficacy of two different immunosuppressive regimens in patients with chronic vogt-koyanagi-harada disease.
Cuchacovich M; Solanes F; Díaz G; Cermenati T; Avila S; Verdaguer J; Verdaguer JI; Carpentier C; Stopel J; Rojas B; Traipe L; Gallardo P; Sabugo F; Zanoli M; Merino G; Villarroel F
Ocul Immunol Inflamm; 2010 Jun; 18(3):200-7. PubMed ID: 20482399
[TBL] [Abstract][Full Text] [Related]
32. Vogt-Koyanagi-Harada Syndrome in Brazilian Children.
Marquezan MC; Nascimento H; Dalbem D; Muccioli C; Belfort R
Ocul Immunol Inflamm; 2020 Apr; 28(3):402-408. PubMed ID: 31120768
[No Abstract] [Full Text] [Related]
33. Retinal cystoid spaces in acute Vogt-Koyanagi-Harada syndrome.
Tsujikawa A; Yamashiro K; Yamamoto K; Nonaka A; Fujihara M; Kurimoto Y
Am J Ophthalmol; 2005 Apr; 139(4):670-7. PubMed ID: 15808163
[TBL] [Abstract][Full Text] [Related]
34. [Vogt-Koyanagi-Harada syndrome: a serious and rare emergency in children].
Venaille A; Palombi K; Templier I; Bouillet L; Pagnier A; Debillon T; Bourdat-Michel G
Arch Pediatr; 2011 Jan; 18(1):33-6. PubMed ID: 21055910
[TBL] [Abstract][Full Text] [Related]
35. [Rare form of uveitis with neurological symptoms: the Vogt-Koyanagi-Harada uveomeningoencephalitic syndrome].
Kätterer C; Kaeser HE; Steiger U
Schweiz Med Wochenschr; 1992 Feb; 122(8):269-74. PubMed ID: 1542780
[TBL] [Abstract][Full Text] [Related]
36. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy.
Paredes I; Ahmed M; Foster CS
Ocul Immunol Inflamm; 2006 Apr; 14(2):87-90. PubMed ID: 16597537
[TBL] [Abstract][Full Text] [Related]
37. Vogt-Koyanagi-Harada syndrome in a 4-year old child.
Cunningham ET; Demetrius R; Frieden IJ; Emery HM; Irvine AR; Good WV
Am J Ophthalmol; 1995 Nov; 120(5):675-7. PubMed ID: 7485374
[TBL] [Abstract][Full Text] [Related]
38. Vogt-Koyanagi-Harada disease in the developing world.
Concha del Río LE; Arellanes-García L
Int Ophthalmol Clin; 2010; 50(2):189-99. PubMed ID: 20375871
[No Abstract] [Full Text] [Related]
39. Revised diagnostic criteria for vogt-koyanagi-harada disease: considerations on the different disease categories.
da Silva FT; Damico FM; Marin ML; Goldberg AC; Hirata CE; Takiuti PH; Olivalves E; Yamamoto JH
Am J Ophthalmol; 2009 Feb; 147(2):339-345.e5. PubMed ID: 18992868
[TBL] [Abstract][Full Text] [Related]
40. Clinical Outcomes of Patients with Vogt-Koyanagi-Harada Disease Over 12 Years at a Tertiary Center.
Arevalo JF; Lasave AF; Gupta V; Kozak I; Al Harbi MB; Al Rushood AA; Al Dhibi HA
Ocul Immunol Inflamm; 2016 Oct; 24(5):521-9. PubMed ID: 26399962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
